The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Open accessAbstract
The steroid hormone aldosterone regulates sodium and potassium homeostasis. Aldosterone and activation of the mineralocorticoid receptor also causes inflammation and fibrosis of the heart, fibrosis and remodelling of blood vessels and tubulointerstitial fibrosis and glomerular injury in the kidney. Aldosterone and mineralocorticoid-receptor activation initiate an inflammatory response by increasing the generation of reactive oxygen species by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and mitochondria. High salt intake potentiates these effects, in part by activating the Rho family member Rac1, a regulatory subunit of reduced NADPH oxidase that activates the mineralocorticoid receptor. Studies in mice in which the mineralocorticoid receptor has been deleted from specific cell types suggest a key role for macrophages in promoting inflammation and fibrosis. Aldosterone can exert mineralocorticoid-receptor-independent effects via the angiotensin II receptor and via G-protein-coupled receptor 30. Mineralocorticoid-receptor antagonists are associated with decreased mortality in patients with heart disease and show promise in patients with kidney injury, but can elevate serum potassium concentration. Studies in rodents genetically deficient in aldosterone synthase or treated with a pharmacological aldosterone-synthase inhibitor are providing insight into the relative contribution of aldosterone compared with the contribution of mineralocorticoid-receptor activation in inflammation, fibrosis, and injury. Aldosterone-synthase inhibitors are under development in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Zannad, F., Alla, F., Dousset, B., Perez, A., & Pitt, B. (2000) · Circulation · doi:10.1161/01.cir.102.22.2700 · Cited by 947
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 655
Aldosterone-Induced Inflammation in the Rat Heart
Sun, Y., Zhang, J., Lu, L., Chen, S. S., Quinn, M. T., & Weber, K. T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64454-9 · Cited by 567
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
Blasi, E. R., Rocha, R., Rudolph, A. E., Blomme, E. A. G., Polly, M. L., & McMahon, E. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00929.x · Cited by 542
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505
Plasma sodium stiffens vascular endothelium and reduces nitric oxide release
Oberleithner, H., Riethmüller, C., Schillers, H., MacGregor, G. A., de Wardener, H. E., & Hausberg, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707791104 · Cited by 480
Role of aldosterone in the remnant kidney model in the rat.
Greene, E. L., Kren, S., & Hostetter, T. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118867 · Cited by 479
Shibata, S., Nagase, M., Yoshida, S., Kawarazaki, W., Kurihara, H., Tanaka, H., Miyoshi, J., Takai, Y., & Fujita, T. (2008) · Nature Medicine · doi:10.1038/nm.1879 · Cited by 459
sgk Is an Aldosterone-induced Kinase in the Renal Collecting Duct
Náray-Fejes-Tóth, A., Canessa, C., Cleaveland, E. S., Aldrich, G., & Fejes-Tóth, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16973 · Cited by 454
Brilla, C. G., Matsubara, L. S., & Weber, K. T. (1993) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1993.1066 · Cited by 425
Usher, M. G., Duan, S. Z., Ivaschenko, C. Y., Frieler, R. A., Berger, S., Schütz, G., Lumeng, C. N., & Mortensen, R. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41080 · Cited by 383
Snyder, P. M., Olson, D. R., & Thomas, B. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100623200 · Cited by 381
Podocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1
Shibata, S., Nagase, M., Yoshida, S., Kawachi, H., & Fujita, T. (2007) · Hypertension · doi:10.1161/01.hyp.0000255636.11931.a2 · Cited by 362
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Calvier, L., Miana, M., Reboul, P., Cachofeiro, V., Martinez-Martinez, E., de Boer, R. A., Poirier, F., Lacolley, P., Zannad, F., Rossignol, P., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300569 · Cited by 359
Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors
McCurley, A., Pires, P. W., Bender, S. B., Aronovitz, M., Zhao, M. J., Metzger, D., Chambon, P., Hill, M. A., Dorrance, A. M., Mendelsohn, M. E., et al. (2012) · Nature Medicine · doi:10.1038/nm.2891 · Cited by 347
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
Leopold, J. A., Dam, A., Maron, B. A., Scribner, A. W., Liao, R., Handy, D. E., Stanton, R. C., Pitt, B., & Loscalzo, J. (2007) · Nature Medicine · doi:10.1038/nm1545 · Cited by 346
Guo, C., Ricchiuti, V., Lian, B. Q., Yao, T. M., Coutinho, P., Romero, J. R., Li, J., Williams, G. H., & Adler, G. K. (2008) · Circulation · doi:10.1161/circulationaha.107.748640 · Cited by 342
Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J., Shah, A. M., Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J., & Shah, A. M. (2006) · The FASEB Journal · doi:10.1096/fj.05-4642fje · Cited by 318
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.
Lombès, M., Oblin, M. E., Gasc, J. M., Baulieu, E. E., Farman, N., & Bonvalet, J. P. (1992) · Circulation Research · doi:10.1161/01.res.71.3.503 · Cited by 309
Rickard, A. J., Morgan, J., Tesch, G., Funder, J. W., Fuller, P. J., & Young, M. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.131110 · Cited by 303
Vinh, A., Chen, W., Blinder, Y., Weiss, D., Taylor, W. R., Goronzy, J. J., Weyand, C. M., Harrison, D. G., & Guzik, T. J. (2010) · Circulation · doi:10.1161/circulationaha.109.930446 · Cited by 300
Effects of endothelins on collagen turnover in cardiac fibroblasts
Guarda, E., Katwa, L. C., Myers, P. R., Tyagi, S. C., & Weber, K. T. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2130 · Cited by 291
Caprio, M., Newfell, B. G., la Sala, A., Baur, W., Fabbri, A., Rosano, G., Mendelsohn, M. E., & Jaffe, I. Z. (2008) · Circulation Research · doi:10.1161/circresaha.108.174235 · Cited by 285
Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure
Qin, W., Rudolph, A. E., Bond, B. R., Rocha, R., Blomme, E. A. G., Goellner, J. J., Funder, J. W., & McMahon, E. G. (2003) · Circulation Research · doi:10.1161/01.res.0000080521.15238.e5 · Cited by 262
Mihailidou, A. S., Loan Le, T. Y., Mardini, M., & Funder, J. W. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136242 · Cited by 262
Keidar, S., Kaplan, M., Pavlotzky, E., Coleman, R., Hayek, T., Hamoud, S., & Aviram, M. (2004) · Circulation · doi:10.1161/01.cir.0000127949.05756.9d · Cited by 244
Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice
Virdis, A., Neves, M. F., Amiri, F., Touyz, R. M., & Schiffrin, E. L. (2004) · Journal of Hypertension · doi:10.1097/00004872-200403000-00016 · Cited by 244
Gros, R., Ding, Q., Sklar, L. A., Prossnitz, E. E., Arterburn, J. B., Chorazyczewski, J., & Feldman, R. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.161653 · Cited by 243
Oxidation of CaMKII determines the cardiotoxic effects of aldosterone
He, B. J., Joiner, M.-L. A., Singh, M. V., Luczak, E. D., Swaminathan, P. D., Koval, O. M., Kutschke, W., Allamargot, C., Yang, J., Guan, X., et al. (2011) · Nature Medicine · doi:10.1038/nm.2506 · Cited by 240
Shibata, S., Mu, S., Kawarazaki, H., Muraoka, K., Ishizawa, K.-I., Yoshida, S., Kawarazaki, W., Takeuchi, M., Ayuzawa, N., Miyoshi, J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43124 · Cited by 236
Lacolley, P., Labat, C., Pujol, A., Delcayre, C., Benetos, A., & Safar, M. (2002) · Circulation · doi:10.1161/01.cir.0000039328.33137.6c · Cited by 229
T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury
Kasal, D. A., Barhoumi, T., Li, M. W., Yamamoto, N., Zdanovich, E., Rehman, A., Neves, M. F., Laurant, P., Paradis, P., & Schiffrin, E. L. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.181123 · Cited by 228
Calhoun, D. A., White, W. B., Krum, H., Guo, W., Bermann, G., Trapani, A., Lefkowitz, M. P., & Ménard, J. (2011) · Circulation · doi:10.1161/circulationaha.111.029892 · Cited by 227
Fraccarollo, D., Berger, S., Galuppo, P., Kneitz, S., Hein, L., Schütz, G., Frantz, S., Ertl, G., & Bauersachs, J. (2011) · Circulation · doi:10.1161/circulationaha.110.983023 · Cited by 226
Aldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle Cells
Mazak, I., Fiebeler, A., Muller, D. N., Park, J.-K., Shagdarsuren, E., Lindschau, C., Dechend, R., Viedt, C., Pilz, B., Haller, H., et al. (2004) · Circulation · doi:10.1161/01.cir.0000131860.80444.ab · Cited by 218
Fiebeler, A., Schmidt, F., Müller, D. N., Park, J.-K., Dechend, R., Bieringer, M., Shagdarsuren, E., Breu, V., Haller, H., & Luft, F. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.787 · Cited by 213
Amar, L., Azizi, M., Menard, J., Peyrard, S., Watson, C., & Plouin, P.-F. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157271 · Cited by 202
Aldosterone Promotes Autoimmune Damage by Enhancing Th17-Mediated Immunity
Herrada, A. A., Contreras, F. J., Marini, N. P., Amador, C. A., González, P. A., Cortés, C. M., Riedel, C. A., Carvajal, C. A., Figueroa, F., Michea, L. F., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0802886 · Cited by 191
Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis
Rerolle, J.-P., Hertig, A., Nguyen, G., Sraer, J.-D., & Rondeau, E. P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00355.x · Cited by 188
Molecular Mechanism of the Inhibitory Effect of Aldosterone on Endothelial NO Synthase Activity
Nagata, D., Takahashi, M., Sawai, K., Tagami, T., Usui, T., Shimatsu, A., Hirata, Y., & Naruse, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000226054.53527.bb · Cited by 187
Osteopontin Plays an Important Role in the Development of Medial Thickening and Neointimal Formation
Isoda, K., Nishikawa, K., Kamezawa, Y., Yoshida, M., Kusuhara, M., Moroi, M., Tada, N., & Ohsuzu, F. (2002) · Circulation Research · doi:10.1161/01.res.0000025268.10302.0c · Cited by 183
Brown, N. J., Kim, K.-S., Chen, Y.-Q., Blevins, L. S., Nadeau, J. H., Meranze, S. G., & Vaughan, D. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6305 · Cited by 182
Self-citationAldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ Damage
Fiebeler, A., Nussberger, J., Shagdarsuren, E., Rong, S., Hilfenhaus, G., Al-Saadi, N., Dechend, R., Wellner, M., Meiners, S., Maser-Gluth, C., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.521625 · Cited by 182
Grossmann, C., Benesic, A., Krug, A. W., Freudinger, R., Mildenberger, S., Gassner, B., & Gekle, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0469 · Cited by 178
Min, L.-J., Mogi, M., Li, J.-M., Iwanami, J., Iwai, M., & Horiuchi, M. (2005) · Circulation Research · doi:10.1161/01.res.0000180753.63183.95 · Cited by 170
Nedd4-2 Modulates Renal Na+-Cl− Cotransporter via the Aldosterone-SGK1-Nedd4-2 Pathway
Arroyo, J. P., Lagnaz, D., Ronzaud, C., Vázquez, N., Ko, B. S., Moddes, L., Ruffieux-Daidié, D., Hausel, P., Koesters, R., Yang, B., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011020132 · Cited by 169
Lother, A., Berger, S., Gilsbach, R., Rösner, S., Ecke, A., Barreto, F., Bauersachs, J. K., Schütz, G., & Hein, L. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.163287 · Cited by 152
Rude, M. K., Duhaney, T.-A. S., Kuster, G. M., Judge, S., Heo, J., Colucci, W. S., Siwik, D. A., & Sam, F. (2005) · Hypertension · doi:10.1161/01.hyp.0000176236.55322.18 · Cited by 150
Rozansky, D. J., Cornwall, T., Subramanya, A. R., Rogers, S. L., Yang, Y.-F., David, L. L., Zhu, X., Yang, C., & Ellison, D. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38323 · Cited by 148
Michea, L., Delpiano, A. M., Hitschfeld, C., Lobos, L., Lavandero, S., & Marusic, E. T. (2004) · Endocrinology · doi:10.1210/en.2004-1130 · Cited by 147
Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin
Zhang, A., Jia, Z., Guo, X., & Yang, T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00480.2006 · Cited by 146
Yang, M. H., Zheng, J., Miao, Y., Wang, Y., Cui, W., Guo, J., Qiu, S., Han, Y., Jia, L., Li, H., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.248732 · Cited by 141
Genetic Deficiency of Plasminogen Activator Inhibitor-1 Promotes Cardiac Fibrosis in Aged Mice
Ghosh, A. K., Bradham, W. S., Gleaves, L. A., Taeye, B. M. D., Murphy, S. B., Covington, J. W., & Vaughan, D. E. (2010) · Circulation · doi:10.1161/circulationaha.110.955245 · Cited by 138
Bienvenu, L. A., Morgan, J., Rickard, A. J., Tesch, G. H., Cranston, G. A., Fletcher, E. K., Delbridge, L. M. D., & Young, M. J. (2012) · Endocrinology · doi:10.1210/en.2011-2098 · Cited by 135
Aldosterone Induces Superoxide Generation via Rac1 Activation in Endothelial Cells
Iwashima, F., Yoshimoto, T., Minami, I., Sakurada, M., Hirono, Y., & Hirata, Y. (2007) · Endocrinology · doi:10.1210/en.2007-0864 · Cited by 134
Rapid Nongenomic Effects of Aldosterone in Mineralocorticoid-Receptor-Knockout Mice
Rossol-Haseroth, K., Gerdes, D., Berger, S. M., Feuring, M., Guenther, A., Herbst, C., Christ, M., & Wehling, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1771 · Cited by 134
Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1
Park, J. B., & Schiffrin, E. L. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02291-9 · Cited by 127
Mitochondrial Dysfunction Mediates Aldosterone-Induced Podocyte Damage
Zhu, C., Huang, S., Yuan, Y., Ding, G., Chen, R., Liu, B., Yang, T., & Zhang, A. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.029 · Cited by 125
Sato, A., & Funder, J. W. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828470 · Cited by 125
Calò, L. A., Zaghetto, F., Pagnin, E., Davis, P. A., de Mozzi, P., Sartorato, P., Martire, G., Fiore, C., & Armanini, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031545 · Cited by 122
Christ, M., Meyer, C., Sippel, K., et al. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2106 · Cited by 121
PKCε modulates NF-κB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes
Li, R. C. X., Ping, P., Zhang, J., Wead, W. B., Cao, X., Gao, J., Zheng, Y., Huang, S., Han, J., & Bolli, R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.4.h1679 · Cited by 118
Rapid, Nongenomic Effects of Aldosterone in the Heart Mediated by ε Protein Kinase C
Mihailidou, A. S., Mardini, M., & Funder, J. W. (2003) · Endocrinology · doi:10.1210/en.2003-1137 · Cited by 117
Yuan, Y., Chen, Y., Zhang, P., Huang, S., Zhu, C., Ding, G., Liu, B., Yang, T., & Zhang, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.015 · Cited by 116
Moriwaki, H., Stempien‐Otero, A., Kremen, M., Cozen, A. E., & Dichek, D. A. (2004) · Circulation Research · doi:10.1161/01.res.0000141427.61023.f4 · Cited by 115
Aldosterone Activates NF-κB in the Collecting Duct
Leroy, V. A. A., de Seigneux, S., Agassiz, V., Hasler, U., Rafestin-Oblin, M. E., Vinciguerra, M., Martin, P., & Féraille, E. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020232 · Cited by 115
Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype
Gerling, I., Sun, Y., Ahokas, R. A., Wodi, L. A., Bhattacharya, S. K., Warrington, K. J., Postlethwaite, A. E., & Weber, K. T. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00113.2003 · Cited by 112
Hirono, Y., Yoshimoto, T., Suzuki, N., Sugiyama, T., Sakurada, M., Takai, S., Kobayashi, N., Shichiri, M., & Hirata, Y. (2007) · Endocrinology · doi:10.1210/en.2006-1157 · Cited by 110
Oxidative Stress Causes Mineralocorticoid Receptor Activation in Rat Cardiomyocytes
Nagase, M., Ayuzawa, N., Kawarazaki, W., Ishizawa, K., Ueda, K., Yoshida, S., & Fujita, T. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.185520 · Cited by 110
Weisberg, A. D., Albornoz, F., Griffin, J. P., Crandall, D. L., Elokdah, H. M., Fogo, A. B., Vaughan, D. E., & Brown, N. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000152356.85791.52 · Cited by 108
Self-citationDisinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ
Bhalla, V., Soundararajan, R., Pao, A. C., Li, H., & Pearce, D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00061.2006 · Cited by 108
Aldosterone synthase inhibition in humans
Azizi, M., Amar, L., & Ménard, J. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs388 · Cited by 107
Stas, S. N., Whaley‐Connell, A. T., Habibi, J., Appesh, L., Hayden, M. R., Karuparthi, P. R., Qazi, M., Morris, E. M., Cooper, S. A., Link, C. D., et al. (2007) · Endocrinology · doi:10.1210/en.2006-1691 · Cited by 103
Kawarazaki, W., Nagase, M., Yoshida, S., Takeuchi, M., Ishizawa, K., Ayuzawa, N., Ueda, K., & Fujita, T. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070734 · Cited by 102
Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation
Huang, S., Zhang, A., Ding, G., & Chen, R. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90428.2008 · Cited by 99
Effect of aldosterone on renal transforming growth factor-β
Juknevicius, I., Segal, Y., Kren, S. M., et al. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00202.2003 · Cited by 98
Aldosterone-Specific Activation of Cardiomyocyte Mineralocorticoid Receptor In Vivo
Messaoudi, S., Gravez, B., Tarjus, A., Pelloux, V., Ouvrard‐Pascaud, A., Delcayre, C., Samuel, J., Launay, J., Sierra‐Ramos, C., de la Rosa, D. Á., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.112.198986 · Cited by 98
Homeostatic Responses in the Adrenal Cortex to the Absence of Aldosterone in Mice
Lee, G., Makhanova, N., Caron, K. M., Sequeira-Lόpez, M. L. S., Gómez, R. A., Smithies, O., & Kim, H. (2005) · Endocrinology · doi:10.1210/en.2004-1102 · Cited by 97
Seccia, T. M., Belloni, A. S., Kreutz, R., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02860-7 · Cited by 97
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury
Ma, J., Weisberg, A. D., Griffin, J. P., Vaughan, D. E., Fogo, A. B., & Brown, N. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000201 · Cited by 96
Self-citationMechanistic aspects of mineralocorticoid receptor activation
Hellal-Lévy, C., Fagart, J., Souque, A., & Rafestin-Oblin, M. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00958.x · Cited by 93
Oestreicher, E. M., Martinez-Vasquez, D., Stone, J. R., Jonasson, L., Roubsanthisuk, W., Mukasa, K., & Adler, G. K. (2003) · Circulation · doi:10.1161/01.cir.0000097000.51723.6f · Cited by 93
Lemarié, C. A., Simeone, S., Nikonova, A. S., Ebrahimian, T., Deschênes, M.-E., Coffman, T. M., Paradis, P., & Schiffrin, E. L. (2009) · Circulation Research · doi:10.1161/circresaha.109.196576 · Cited by 92
In vivo interactions of TGF-β and extracellular matrix
Noble, N. A., Harper, J. R., & Border, W. A. (1992) · Progress in Growth Factor Research · doi:10.1016/0955-2235(92)90017-c · Cited by 90
Placental growth factor mediates aldosterone-dependent vascular injury in mice
Jaffe, I. Z., Newfell, B. G., Aronovitz, M. A., Mohammad, N. N., McGraw, A. P., Perreault, R. E., Carmeliet, P., Ehsan, A., & Mendelsohn, M. E. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40205 · Cited by 84
Großmann, C., Krug, A. W., Freudinger, R., Mildenberger, S., Voelker, K., & Gekle, M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00708.2006 · Cited by 82
Firewall function of the endothelial glycocalyx in the regulation of sodium homeostasis
Korte, S., Wiesinger, A., Straeter, A. S., Peters, W., Oberleithner, H., & Kusche‐Vihrog, K. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-1038-y · Cited by 80
Sam, F. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.10.007 · Cited by 79
Batenburg, W. W., Jansen, P. M., van den Bogaerdt, A. J., & Danser, A. H. J. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs016 · Cited by 76
Huang, W. G., Chen, X., Kahng, K. W., Noble, N. A., Border, W. A., & Huang, Y. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00017.2008 · Cited by 75
Salt Excess Causes Left Ventricular Diastolic Dysfunction in Rats With Metabolic Disorder
Matsui, H., Ando, K., Kawarazaki, H., Nagae, A., Fujita, M., Shimosawa, T., Nagase, M., & Fujita, T. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.111815 · Cited by 75
Lee, S. H., Yoo, T., Nam, B.-Y., Kim, D. K., Li, J. J., Jung, D.-S., Kwak, S.-J., Ryu, D., Han, S. H., Lee, J. E., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2009 · Cited by 73
Ogawa, Y., Mukoyama, M., Yokoi, H., Kasahara, M., Mori, K., Kato, Y. H., Kuwabara, T., Imamaki, H., Kawanishi, T., Koga, K., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011100985 · Cited by 71
Kidney function in mice lacking aldosterone
Makhanova, N., Lee, G., Takahashi, N., Sequeira-Lόpez, M. L. S., Gómez, R. A., Kim, H., & Smithies, O. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00257.2005 · Cited by 70
Luther, J. M., Luo, P., Wang, Z., Cohen, S., Kim, H., Fogo, A. B., & Brown, N. J. (2012) · Kidney International · doi:10.1038/ki.2012.170 · Cited by 70
Self-citationAldosterone Modulates Steroid Receptor Binding to the Endothelin-1 Gene (edn1)
Stow, L. R., Gumz, M. L., Lynch, I. J., Greenlee, M. M., Rudin, A., Cain, B. D., & Wingo, C. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030718 · Cited by 69
Irita, J., Okura, T., Jotoku, M., Nagao, T., Enomoto, D., Kurata, M., Desilva, V. R., Miyoshi, K., Matsui, Y., Uede, T., et al. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00557.2010 · Cited by 67
Giusti, V. C. D., Nolly, M. B., Yeves, A. M., Caldiz, C. I., Villa‐Abrille, M. C., de Cingolani, G. E. C., Ennis, I. L., Cingolani, H. E., & Aiello, E. A. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.176024 · Cited by 66
Terada, Y., Ueda, S., Hamada, K., Shimamura, Y., Ogata, K., Inoue, K., Taniguchi, Y., Kagawa, T., Horino, T., & Takao, T. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0498-x · Cited by 64
Yoshida, K., Kim‐Mitsuyama, S., Wake, R., Izumiya, Y., Izumi, Y., Yukimura, T., Ueda, M., Yoshiyama, M., & Iwao, H. (2005) · Hypertension Research · doi:10.1291/hypres.28.447 · Cited by 60
Aldosterone activates endothelial exocytosis
Jeong, Y., Chaupin, D. F., Matsushita, K., Yamakuchi, M., Cameron, S. J., Morrell, C. N., & Lowenstein, C. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804037106 · Cited by 59
Aldosterone Inhibits Inducible Nitric Oxide Synthase in Neonatal Rat Cardiomyocytes
Chun, T.-Y., Bloem, L. J., & Pratt, J. H. (2003) · Endocrinology · doi:10.1210/en.2002-220956 · Cited by 54
Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes
Chun, T.-Y., & Pratt, J. H. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.03.016 · Cited by 52
Artunç, F., Amann, K., Nasir, O., Friedrich, B., Sandulache, D., Jahovic, N., Risler, T., Vallon, V., Wulff, P., Kuhl, D., et al. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0082-0 · Cited by 51
Aldosterone up-regulates production of plasminogen activator inhibitor-1 by renal mesangial cells.
Yuan, J., Jia, R., & Bao, Y. (2007) · Journal of biochemistry and molecular biology · doi:10.5483/bmbrep.2007.40.2.180 · Cited by 45
Zhang, A., Jia, Z., Wang, N., Tidwell, T. J., & Yang, T. (2011) · Kidney International · doi:10.1038/ki.2011.29 · Cited by 45
Griol‐Charhbili, V., Fassot, C., Messaoudi, S., Perret, C., Agrapart, V., & Jaisser, F. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.153619 · Cited by 40
Amar, L., Azizi, M., Ménard, J., Peyrard, S., & Plouin, P. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835d6d49 · Cited by 38
Role of mineralocorticoid action in the brain in salt‐sensitive hypertension
Oki, K., Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05538.x · Cited by 34
Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
Volk, M. J., Bomback, A. S., & Klemmer, P. J. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0202-2 · Cited by 34
Young, M. J., Morgan, J., Brolin, K., Fuller, P. J., & Funder, J. W. (2010) · Endocrinology · doi:10.1210/en.2009-1476 · Cited by 31
Fu, G., Xu, C., Zhong, Y., et al. (2012) · Endocrine · doi:10.1007/s12020-012-9675-2 · Cited by 29
Gamliel-Lazarovich, A., Gantman, A., Coleman, R., Jeng, A. Y., Kaplan, M., & Keidar, S. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833c2197 · Cited by 26
Gong, R., Morris, D. J., & Brem, A. S. (2008) · Steroids · doi:10.1016/j.steroids.2008.05.009 · Cited by 22
Rickard, A. J., Funder, J. W., Morgan, J., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0209 · Cited by 19
Messaoudi, S., Zhang, A. D., Griol‐Charhbili, V., Escoubet, B., Sadoshima, J., Farman, N., & Jaisser, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030156 · Cited by 17
Cited by
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Daruich, A., Matet, A., Dirani, A., Bousquet, E., Zhao, M., Farman, N., Jaisser, F., & Behar-Cohen, F. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.05.003 · Cited by 989
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Agarwal, R., Kolkhof, P., Bakris, G., Bauersachs, J., Haller, H., Wada, T., & Zannad, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa736 · Cited by 638
The pathophysiology of hypertension in patients with obesity
DeMarco, V. G., Aroor, A. R., & Sowers, J. R. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.44 · Cited by 545
Shen, Y., Wang, X., Lu, J., Salfenmoser, M., Wirsik, N. M., Schleussner, N., Imle, A., Freire Valls, A., Radhakrishnan, P., Liang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.005 · Cited by 339
Metadata
- Authors
- Brown, N. J.
- Venue
- Nature Reviews Nephrology
- Published
- 2013-06-18
- Volume
- 9
- Issue
- 8
- Pages
- 459-469
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2067956701
- Cited by
- 451
- References
- 122
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.